Novaccess Global Inc's ROA from the fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Novaccess Global Inc's ROA in the fourth quarter of 2024?
Novaccess Global Inc achieved a return on average assets (ROA) of 72.56 % in its fourth quarter of 2024, this is above XSNX's average return on assets of -4893.02%.
Novaccess Global Inc assets over the 12 months ending in its fourth quarter of 2024 are valued at $2 million

ROA has improved compared to -1145.74% in the third quarter of 2024, due to net income growth.

However, within the Healthcare sector Novaccess Global Inc achieved the highest return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2024 quarter, so far to 5165, from total ROA ranking in the third quarter of 2024 at 5247.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2024) IV. Quarter	(Jun 30 2024) III. Quarter	(Mar 31 2024) II. Quarter	(Dec 31 2023) I. Quarter	(Sep 30 2023) IV. Quarter
Y / Y Total Assets Change	9365.29 %	179.87 %	-17.17 %	-70.34 %	-50.12 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	1	-2	-2	-1	-5
Return On Assets (TTM)	72.56 %	-1145.74 %	-2028.3 %	-926.4 %	-4752.59 %
XSNX's Total Ranking	# 5165	# 5247	# 5968	# 5433	# 5543
Total Assets (TTM) in million	6	0	0	0	0
Seq. Total Assets Change	1089.97 %	478.27 %	393.15 %	-72.11 %	-64.82 %
Seq. Net Income Change	-	-	-	-	-

XSNX's 5 Years Annual ROA >> Back to XSNX Management Effectiveness >> Compare XSNX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 0
Sector	# 1
Overall	# 9

Return On Assets Statistics
High	Average	Low
1741.86 %	-4893.02 %	-93155.56 %
(Jun 30 2019)		(Mar 31 2021)

Financial Statements
Novaccess Global Inc's Assets	$ 6 million	XSNX's Balance sheet
Novaccess Global Inc's Income	$ 1 million	Quarterly XSNX's Income Statement
XSNX's Income by Division		See XSNX's Income by Division

Annual Return On Assets	(Sep 30 2024) FY 2024	(Sep 30 2023) FY 2023	(Sep 30 2022) FY 2022	(Sep 30 2021) FY 2021	(Sep 30 2020) FY 2020
Y / Y Total Assets Change	9365.29 %	-50.12 %	-39.99 %	116829.21 %	-99.92 %
Total Assets in million	6	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-3	-5	-2	-3	-7
Annual Return On Assets	-45.08 %	-7655.69 %	-1373.84 %	-1207.14 %	-3803491.57 %

XSNX's 5 Years Annual ROA >> Back to XSNX Management Effectiveness >> Compare XSNX ROA to its Competitors

More Return On Assets Ratios
XSNX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
XSNX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for XSNX's Competitors
Subscribers only: Roa for Novaccess Global Inc's Suppliers
Subscribers only: Return On Assets for XSNX's Customers

You may also want to know
XSNX's Roi	XSNX's Inventory Turnover Ratio	XSNX's Growth Rates	XSNX's Dividend Comparisons
	XSNX's Profitability Ratios	XSNX's Asset Turnover Ratio	XSNX's Dividend Growth
XSNX's Roe	XSNX's Valuation Ratios	XSNX's Financial Strength Ratios	XSNX's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2024, within Healthcare Sector	ROA
AnTix Holdings, Inc.	171.97 %
Orgenesis Inc	133.39 %
Camp4 Therapeutics Corporation	77.31 %
Oak Woods Acquisition Corp	76.68 %
Gridai Technologies Corp	76.64 %
Roivant Sciences Ltd	68.55 %
Agios Pharmaceuticals Inc	61.98 %
Earth Science Tech Inc	54.91 %
Keenova Therapeutics Plc	51.31 %
Entera Bio Ltd	49.15 %
Mimedx Group Inc	44.01 %
Valion Bio Inc	43.87 %
Longduoduo Co Ltd	43.20 %
Dariohealth Corp	40.74 %
Edwards Lifesciences Corporation	39.41 %
Siga Technologies Inc	38.72 %
Interpace Biosciences Inc	37.87 %
Exelixis Inc	37.17 %
Protagonist Therapeutics inc	30.98 %
Pharmacyte Biotech Inc	30.36 %
Pavmed Inc	28.16 %
Tg Therapeutics Inc	26.98 %
Sbc Medical Group Holdings Incorporated	26.72 %
Idexx Laboratories Inc	25.90 %
Entrada Therapeutics Inc	25.09 %
Mettler toledo International Inc	24.10 %
Engene Therapeutics Inc	23.50 %
Lantheus Holdings Inc	22.89 %
Catalyst Pharmaceuticals Inc	22.01 %
Nrc Health	21.92 %

Date modified: 2026-09-02T21:11:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.